Discharge Opioid Education to Decrease Opioid Use After Cesarean
NCT03678870 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 196
Last updated 2020-02-17
Summary
Background: The number of opioid overdose deaths in the United States has quadrupled in 15 years, a dramatic manifestation of the current opioid abuse epidemic. This rise parallels a sharp increase in the amount of legal prescription opioids dispensed. The abundance of prescription opioids available is a primary pathway for opioid abuse and diversion and higher opioid use after surgery has been associated with an increased risk of chronic opioid use. Reducing the amount of opioid used after cesarean delivery may decrease the risk of chronic opioid use and will help towards better estimating and reducing the amount of opioids prescribed at discharge.
Objective: To to compare discharge opioid education to standard care to ascertain whether opioid education reduces opioid use after hospital discharge
Conditions
- Opioid Use
Interventions
- OTHER
-
Opioid Education Handout
a single page handout with information about how to use medications for pain after discharge.
Sponsors & Collaborators
-
Vanderbilt University Medical Center
lead OTHER
Principal Investigators
-
Sarah Osmundson, MD · Vanderbilt University Medical Center
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-09-01
- Primary Completion
- 2019-02-01
- Completion
- 2019-11-01
Countries
- United States
Study Locations
More Related Trials
-
Decreasing Opioid Misuse and Habit-forming Behaviors Following Prescription in Patients Undergoing Cesarean Section
NCT05461196 ·Status: COMPLETED ·Phase: NA
-
RCT of Counseling Intervention on Post-op Opiate Use
NCT03359798 ·Status: WITHDRAWN ·Phase: NA
-
Determining the Optimal Dose of Intrathecal Morphine for Post-Cesarean Analgesia
NCT07023497 ·Status: RECRUITING ·Phase: NA
-
Does a Single Intravenous Dose of Ketamine Reduce the Need for Supplemental Opioids in Post-Cesarean Section Patients?
NCT00486902 ·Status: COMPLETED ·Phase: NA
-
Educational Video on Pain Management and Subsequent Opioid Use After Cesarean Delivery
NCT03959969 ·Status: COMPLETED ·Phase: NA
-
Intrathecal Opioids for Pain Control After Cesarean Delivery: Determining the Optimal Dose
NCT02009722 ·Status: COMPLETED ·Phase: PHASE4
-
Comparison of Different Methods of Pain Control After Cesarean Section for Patients on Buprenorphine or Methadone
NCT02091297 ·Status: WITHDRAWN ·Phase: NA
-
Respiratory Distress and Elective Cesarean Section at Term
NCT06874478 ·Status: RECRUITING
-
Oxytocin at Elective Cesarean Deliveries: A Dose-finding Study in Women With BMI ≥ 40kg/m2
NCT03957083 ·Status: COMPLETED ·Phase: NA
-
Oxycodone in Serum After Postoperative Oral Oxycodone in Caesarean Sections Under Spinal Anesthesia
NCT02717637 ·Status: COMPLETED
-
Intravenous Methadone Versus Intrathecal Morphine for Analgesia Following Cesarean Delivery
NCT06826742 ·Status: COMPLETED ·Phase: PHASE4
-
Practice of Assisted Vaginal Birth in Egypt
NCT07308977 ·Status: RECRUITING
-
Carbetocin Versus Oxytocin and Ergometrine for the Prevention of Postpartum Hemorrhage
NCT03578263 ·Status: COMPLETED ·Phase: NA
-
Spontaneous and Oxytocin-induced Contractility After Exposure to Intravenous Anesthetic Agents: an In-vitro Study in Human Myometrium
NCT03852797 ·Status: COMPLETED ·Phase: NA
-
Pharmacokinetics of Oxytocin at Cesarean Delivery
NCT03898882 ·Status: COMPLETED
-
Minimum Oxytocin Dose for Cesarean During Labor: Adaptative Clinical Trial
NCT02794779 ·Status: UNKNOWN ·Phase: PHASE3
-
Understanding the Postpartum Pain Experience in Women of Minority Race/Ethnicity
NCT04601246 ·Status: COMPLETED
-
Intrathecal Hydromorphone vs Intrathecal Morphine to Treat Post Cesarean Pain in Patients With Opioid Use Disorder Taking Buprenorphine
NCT06784180 ·Status: WITHDRAWN ·Phase: PHASE4
-
Oxytocin Induction in Full Term Pregnant Women With Cesarean Section of Prelabor Rupture of Membranes
NCT05333731 ·Status: UNKNOWN
-
Outcomes After the Implementation of a New Oxytocin Protocol
NCT02722356 ·Status: COMPLETED ·Phase: NA
-
Multimodal Pain Management for Cesarean Delivery
NCT02922985 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Epidural Labor Analgesia With Esketamine on the Incidence of Postpartum Depression in Parturients
NCT05826327 ·Status: RECRUITING ·Phase: PHASE4
-
Carbetocin Versus Oxytocin for the Prevention of Postpartum Hemorrhage in Emergency Caesarean Delivery
NCT03755531 ·Status: COMPLETED ·Phase: PHASE4
-
Randomization of Oxytocin, Oxytocin+Intrauterine Misoprostol and Carbetocin During C-section
NCT05083910 ·Status: COMPLETED ·Phase: NA
-
Pain Score and Opioid Consumption of Index and Previous Cesarean Delivery
NCT06178458 ·Status: NOT_YET_RECRUITING